Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Slides:

Advertisements

Similar presentations

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Advertisements

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.

Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation Fabio F Pasqualotto,

Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle Michael W.

Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women Ana Direito, M.D., Sébastien.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas Vera Grigorieva, MD, Mario Chen-Mok, PhD, Marina.

Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison

The normal variabilities of the menstrual cycle

Urinary reproductive hormone level differences between African American and Caucasian women of reproductive age Susan R Reutman, Ph.D., Grace Kawas LeMasters,

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Time to the final menstrual period

Hypoestrogenic “inactive phases” at the start of the menstrual cycle: changes with age and reproductive stage, and relationship to follicular depletion

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization.

Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Isabelle.

Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D

Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women Ioannis E. Messinis, M.D., Ph.D.,

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle James R. Stelling, M.D., Emily.

A comparison of blood spot vs

Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Association of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cycles Tsung-Hsien.

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Endocrine and chronobiological effects of fasting in women

Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation Amanda.

Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome Annie A. Guedikian, B.S.,

Initial IVF-ET experience with assisted hatching performed 3 days after retrieval followed by day 5 embryo transfer Margaret C. Graham, M.S., Kathleen.

Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1

Human chorionic gonadotropin levels after blastocyst transfer are highly predictive of pregnancy outcome1 Theocharis C Papageorgiou, M.D., Mark P Leondires,

A prospective study of early pregnancy loss in humans

Lipidomics as an emerging tool to predict endometrial receptivity

René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D

Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.

Susanna J. Park, M. D. , Laura T. Goldsmith, Ph. D. , Joan H

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation Maher A. Abdallah, M.D.,

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Tiffany D. Justice, M.D., Steven T. Nakajima, M.D.

Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D

Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles Sandrine Touzet, M.D., Muriel Rabilloud, M.D.,

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol Georg Griesinger, M.D., Anja Dawson, M.D., Askan Schultze-Mosgau,

Luteal estradiol administration strengthens the relationship between day 3 follicle- stimulating hormone and inhibin B levels and ovarian follicular status

Mean versus individual hormonal profiles in the menstrual cycle

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening Tarun Jain, M.D., Michael.

Regulation of assisted reproductive technologies in the United States

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

Effects of metformin on body mass index, menstrual cyclicity, and ovulation induction in women with polycystic ovary syndrome Derek A Haas, M.D., Bruce.

Matthew S. Christman, M. D. , Suzanne R. Gudeman, M. D. , Justin J

Absence of corpus luteum rescue by chorionic gonadotropin in women immunized with a contraceptive vaccine Rahul Pal, Ph.D., Om Singh, Ph.D. Fertility.

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection.

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone.

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies Pete N. Lohstroh, Ph.D, James W.

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Efstratios M Kolibianakis, M.D., Kostas.

Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.

Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles Lauren Johnson, M.D., M.S.C.E., Mary D. Sammel,

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human.

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.

Day 3 morphology is a poor predictor of blastocyst quality in extended culture James Graham, M.S., Taer Han, B.S., Richard Porter, Michael Levy, M.D.,

Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian.

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles David.

William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Ernesto Bosch,

Presentation transcript:

Differences in hormonal characteristics of conceptive versus nonconceptive menstrual cycles Hongxia Li, M.D., Steven T Nakajima, M.D., Jiangang Chen, M.D., Heather E Todd, M.S., James W Overstreet, M.D., Ph.D., Bill L Lasley, Ph.D. Fertility and Sterility Volume 75, Issue 3, Pages 549-553 (March 2001) DOI: 10.1016/S0015-0282(00)01765-9

Figure 1 Serum E2 profile in six pairs of conceptive (open circles) and nonconceptive (closed circles) cycles. Data are presented as mean ± SD. Day 0 is the day of peak urinary FSH concentration. The E2 level is significantly higher on day 0 in conceptive cycles (P<.05, paired t-test). Li. Hormonal characteristics of menstrual cycles. Fertil Steril 2001. Fertility and Sterility 2001 75, 549-553DOI: (10.1016/S0015-0282(00)01765-9)

Figure 2 Urinary estrone conjugate (E1C) profile in 13 pairs of conceptive (open circles) and nonconceptive (closed circles) cycles. Data are presented as mean ± SD. Day 0 is the day of peak urinary FSH concentration. The peak E1C level occurred 2 days later in conceptive cycles compared with nonconceptive cycles. The difference between E1C values in conceptive cycles and nonconceptive cycles was not significant (P>.05, paired t-test). Li. Hormonal characteristics of menstrual cycles. Fertil Steril 2001. Fertility and Sterility 2001 75, 549-553DOI: (10.1016/S0015-0282(00)01765-9)

Figure 3 Urinary FSH profile in 14 pairs of conceptive (open circles) and nonconceptive (closed circles) cycles. Data are presented as mean ± SD. Day 0 is the day of peak urinary FSH concentration. The peak FSH values in conceptive cycles and nonconceptive cycles differed significantly (P<.05, paired t-test). Li. Hormonal characteristics of menstrual cycles. Fertil Steril 2001. Fertility and Sterility 2001 75, 549-553DOI: (10.1016/S0015-0282(00)01765-9)